Poviodine PVP-1 Oral Nasal Spray
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026810/
A potential barrier solution to mitigate COVID-19 Infection.
Excerpts from attached article :
SARS- CoV-2 or novel coronavirus enters the human body through nose and mouth, stays
there for a while, then binds with ACE2
receptor, enters inside cell, multiplies there
and than manifests itself.
Again, Polyvinyl Pyrrolidone
or Povidone Iodine (PVP-I) is a strong
microbicidal agent having 99.99% virucidal
efficacy in its only 0.23% concentration,
irrespective of all known viruses, even in
SARS- CoV-2 (in vitro).
An oro-nasal spray is designed to apply the PVP-I in nose and oral cavity to gain a protective layer or coating over nasal and oral mucosa, so that SARS-CoV-2 can’t bind with the ACE-2 receptor and prevent their entry inside.
So, it should be effective for prevention of COVID-19 infection. Moreover, as PVP-I has the ability for destruction of SARS-CoV-2, transmission of SARS- CoV-2 from patient should be reduced.
Thus PVP-I oro-nasal spray can act as
an effective shield for COVID-19 protection
for healthcare workers, and for all.
The author proposed (made and started using) an Oro-Nasal Spray, which can be used in nose as well as throat. It’s nothing but 0.6% PVP-I
solution, kept in a simple nasal spray device.
To prevent COVID-19 transmission from
patient to HCW ( health care workers), HCW (asymptomatic
carrier) to common people, or patient of
other disease, this proposed oro-nasal spray
can definitely be helpful.
Safety
The topical application of iodine (in low
concentration) intranasally for the treatment
of recalcitrant chronic rhino-sinusitis has
been described by the St. Paul’s Sinus Centre
team in Vancouver. They found it was
beneficial for the management of this
condition, but also did not lead to any result
in any demonstrable limitation of the
nasal function nor in detectable damage to
the multilayer ciliated epithelium of the
nose.
https://pubmed.ncbi.nlm.nih.gov/32520599/
PPE, mask, hand sanitization or vaccines
nothing proved 100% effective for COVID-
19 prevention till now.
PVP-I oro-nasal spray is an easy tool or way for COVID-19 prevention and reduction of SARS-CoV-2 transmissibility.
The author recommends here, this oro-
nasal spray should be used as an adjunct to
PPE, mask or vaccine. Any person, policy
maker, local or central government could
adopt this safe, cheap, easily available and
effective PVP-I Oro-Nasal spray as an
additional shield of their COVID-19
protection and thus minimize the COVID
burden.
Recommendations
PVP-I Oro Nasal Spray should be used by
doctors or other health care workers (HCW),
COVID-19 patients as well as common
People.
/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026810/
US Clinical Trial
https://clinicaltrials.gov/ct2/show/NCT04364802
Safety- Poison Control Center
https://www.poison.org/articles/povidone-iodine-safe-use-of-a-common-antiseptic-193
HUNWEY 150 Individually Wrapped- Iodine Cotton Swabs Solution Filled| First Aid Swabsticks for Nasal Ears Bruise Travel
Nasal Spray
https://viraldine.com/shop/ols/products/adult-nasal-spray-30ml-100-applications
https://abc7.com/betadine-antiseptic-coronavirus-studies/6376551/
As an eye drop for dry eye and coating any ACE-2 receptors in our eyes
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984652/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300893/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491448/
https://pubmed.ncbi.nlm.nih.gov/32544566/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241406/
https://iovs.arvojournals.org/article.aspx?articleid=2744204
Another reason why N-95 masks are ineffective at preventing transmission because these masks do not cover the eyes which contains ACE-2 receptors.
0.5% Betadine = 1ml 10% Betadine + 19ml H2O ~= 0.5%v/v Betadine aqueous solution.
Other Supporting PubMed/NIH Resources on Poviodine Applications
https://pubmed.ncbi.nlm.nih.gov/?term=povidone+iodine+covid
https://acrobat.adobe.com/link/track?uri=urn:aaid:scds:US:bb746af1-4022-38aa-9752-0c48cecb5445
https://www.aestheticsadvisor.com/2021/05/nasal-spray-COVID-19.html
PS
You know I’ve been questioning the entire idea of the Triple Threat. Let’s think about it.
All these viruses – RSV, Flu, and SARS-COV-2 co-existed the last 2 years during the CV19 pandemic. All are RNA viruses.
Could both RSV and Flu viral infections have been misdiagnosed as being CV19 especially since all 3 have similar, same symptoms, and hospitals received additional
$ for treating CV19 disease, especially with variability of PCR testing and lack of result verification within and between labs who performed those tests?
Also, how likely is it that the other viral infections were suppressed then, but are not now ? Really?
Is triple threat another “crowd controlling” fear tactic to promote more CV19, Flu vaccinations , even though waning antibodies are present – caused by ADE from mRNA spike protein overabundance in vaccinated populations ?
https://academic.oup.com/jid/article/226/12/2064/6582314
https://acrobat.adobe.com/id/urn:aaid:sc:US:cfa5b010-e58c-415d-9d06-f5f086c285eb
https://acrobat.adobe.com/id/urn:aaid:sc:US:4206d296-8b14-4df6-a37d-d3527ff78702
Waning Immunity Against Respiratory Syncytial Virus During the Coronavirus Disease 2019 Pandemic | The Journal of Infectious Diseases | Oxford Academic
Hmm,
Waning immunity against RSV- why? I noted in the entire article there was no data given on how many of the patients blood samples tested were also tested for SARS-COV-2 antibodies or spike proteins present from mRNA inoculations .
Could another cause for low RSV antibodies be due to ADE from an over abundance of spike proteins from mRNA inoculations and boosters ?
Effective Thinking 